BullishWhales · Analysts · Analyst Profile
Analyst rating accuracy & track record
Roanna Ruiz does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.
Ratings & price targets
| Stock | Rating | Price target | Rated | 12-mo vs sector | PT hit |
|---|---|---|---|---|---|
 AKBAAkebia Ther | Buy | $7.00 | Apr 2025 | −46.7% | Miss |
 XERSXeris Pharmaceuticals Inc | Buy | $6.00 | Mar 2025 | +15.7% | Hit |
 VIRVir Biotechnology Inc | Buy | $20.00 | Jan 2025 | −52.2% | Miss |
 SPRYARS Pharmaceuticals, Inc | Buy | $27.00 | Jan 2025 | −14.4% | Miss |
 AQSTAquestive Therapeutics Inc | Buy | $13.00 | Oct 2024 | +27.4% | Miss |
| AQSTAquestive Therapeutics Inc | Buy | $12.00 | Sep 2024 | +25.0% | Miss |
| SPRYARS Pharmaceuticals, Inc | Buy | $25.00 | Sep 2024 | −20.6% | Miss |
| AQSTAquestive Therapeutics Inc | Buy | $8.00 | May 2024 | −9.2% | Miss |
| SPRYARS Pharmaceuticals, Inc | Buy | $18.00 | Mar 2024 | +17.7% | Hit |
| SPRYARS Pharmaceuticals, Inc | Buy | $14.00 | Dec 2022 | −39.7% | Miss |
 ALGSAligos Therapeutics Inc | Buy | $7.00 | Mar 2022 | −46.2% | Miss |
| ALGSAligos Therapeutics Inc | Buy | $11.00 | Mar 2022 | −44.9% | Miss |
| ALGSAligos Therapeutics Inc | Buy | $10.00 | Feb 2022 | −32.8% | Miss |
 AMRNAmarin Corporation PLC | Buy | $10.00 | Feb 2022 | −47.6% | Miss |
| AMRNAmarin Corporation PLC | Buy | $11.00 | Jan 2022 | −53.1% | Miss |
| ALGSAligos Therapeutics Inc | Buy | $15.00 | Jan 2022 | −64.9% | Miss |
 AVIRAtea Pharmaceuticals Inc | Buy | $20.00 | Oct 2021 | −54.5% | Miss |
Go to
Browse the full analyst leaderboardHow analyst accuracy is scored
Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.